KO vs ORCL: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
The Coca-Cola Company Β· Consumer Defensive
$88.71
+15.5% upside to fair value
Med Conviction Grade C High Quality
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric KO ORCL
Current Price $88.71 $149.12
Fair Value Estimate $102.44 $216.22
Upside to Fair Value +15.5% +45.0%
Market Cap $381.7B $429.5B
Forward P/E β€” β€”
EV / EBITDA 20.8x 14.6x
Price / Sales 7.6x 6.0x
Price / FCF 26.7x β€”
Revenue Growth YoY +6.7% +29.6%
Gross Margin 61.9% 63.9%
Operating Margin 29.6% 32.4%
Return on Equity 43.0% 42.6%
Dividend Yield 2.37% 1.34%
FCF Yield 3.75% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
KO β€” The Coca-Cola Company
The Coca-Cola Company is a global non-alcoholic beverage concentrate, brand-management and bottling-system business with products sold in more than 200 countries and territories, supported by powerful trademarks, 2.2 billion daily servings and an entrenched distribution network. Business quality is high: TTM gross, operating and net margins are 61.9%, 29.6% and 28.6%, respectively, ROE is 43.0%, …
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric KO ORCL
Zone Low $76.83 $162.16
Zone High $87.07 $183.79
In Buy Zone? No Yes
← KO Research    ORCL Research β†’    All Research